Semaglutide is a weight-loss medication that mimics a hormone regulating appetite and food intake. In the UK, it is marketed under the brand names Ozempic (for diabetes) and Wegovy (for obesity). It is prescribed to individuals struggling with weight management, often in conjunction with diet and exercise.

Weight lost refers to the reduction in body weight that is typically achieved through lifestyle changes, medications, or bariatric surgeries like the RNY or gastric band. Weight loss, particularly significant or rapid weight loss, can have dramatic positive effects on a person's overall health, reducing the risk of heart disease, diabetes, and other obesity-related conditions. Successful weight loss usually requires long-term changes to diet, exercise, and behavior.

Weight loss help encompasses a wide range of tools, including bariatric surgery, medication (such as appetite suppressants), diet plans, and exercise regimens. For individuals struggling with obesity, working with healthcare professionals like dietitians, bariatric surgeons, and therapists can provide tailored support to achieve long-term weight loss.

The cost of Roux-en-Y (RNY) gastric bypass surgery varies widely depending on the country, hospital, and insurance coverage. In the U.S., it typically ranges between $20,000 and $30,000. In the UK, the procedure may be covered by the NHS if the patient meets specific criteria, or it can be done privately for £8,000 to £15,000.

Weight-loss injections such as Saxenda or Wegovy can lead to side effects like nausea, vomiting, diarrhea, constipation, and abdominal pain. In rare cases, patients may experience gallbladder issues or pancreatitis. It’s important to monitor for side effects and adjust dosage as needed under medical supervision.

Cancer of the Gastrointestinal Tract (GIT) includes cancers that affect the stomach, intestines, esophagus, colon, liver, and pancreas. Symptoms vary depending on the type of cancer but may include weight loss, blood in the stool, or persistent abdominal pain. Early detection is crucial for improving survival rates, and treatment options range from surgery to chemotherapy and radiation.

Endoscopic Sleeve Gastroplasty (ESG) is a non-surgical weight-loss procedure where a gastroenterologist uses an endoscope to stitch the stomach into a smaller size, reducing its capacity. Unlike traditional bariatric surgery, ESG is performed through the mouth and doesn’t involve cutting or removing any part of the stomach. Recovery is quicker, and the procedure is reversible, but the weight loss achieved is typically less significant than with RNY or gastric sleeve surgery.

An abdominal tumor is any abnormal growth located within the abdomen. Tumors can originate from the stomach, intestines, liver, or other abdominal organs. They can be benign or malignant, and treatment often involves surgery, chemotherapy, or radiation therapy, depending on the tumor's size, type, and stage.

Feeling sick in your stomach can indicate nausea, indigestion, or an underlying condition such as gastritis, food intolerance, or stress. If persistent, it’s essential to consult a healthcare provider for proper diagnosis and treatment.

The "fat jab," also known as Saxenda or liraglutide, is an injectable weight-loss drug that has been approved for use on the NHS in the UK for individuals struggling with obesity. It is intended for use in conjunction with a reduced-calorie diet and increased physical activity. The medication helps control appetite, leading to weight loss. It is typically prescribed to those with a BMI over 30 or individuals with weight-related health problems.

Before-and-after images of gastric sleeve patients highlight not only the weight loss but also the excess skin that may remain, especially in areas like the abdomen. Many patients opt for skin removal surgeries after achieving their weight-loss goals.

The cost of gastric band surgery in the UK ranges from £1,450 to £8,000 at private clinics. The NHS may cover the surgery for patients who meet specific health criteria, such as a BMI over 40 or a BMI over 35 with obesity-related health conditions.

Sleeve bariatric surgery, also known as Vertical Sleeve Gastrectomy (VSG), is a restrictive procedure where 80% of the stomach is removed. This reduces stomach capacity, limiting food intake and helping with significant weight loss. It is one of the most popular forms of bariatric surgery due to its effectiveness and relatively lower risk compared to bypass surgeries.

The "Skinny Pen" refers to a weight-loss medication called liraglutide (brand name Saxenda) that is administered through a daily injection. It works by mimicking a hormone that regulates appetite, helping patients feel fuller for longer. This treatment is often used for individuals who struggle with obesity but are not candidates for surgery or who need additional help in managing their weight post-bariatric surgery. The drug is available by prescription and is used in conjunction with diet and exercise.

The balloon pill, also known as the gastric balloon, is a non-surgical weight-loss device that is swallowed and then inflated inside the stomach. It takes up space, helping patients feel fuller on less food. The balloon is temporary and is usually left in place for six months before being removed. It is a popular option for people who want a non-invasive weight-loss method without committing to surgery.